Attention Deficit and Hyperactivity Disorder
Attention Deficit and Hyperactivity Disorder market is segmented by players, region (country), by ... Read More
Global Plasma-derived Medical Product Market Research Report 2024
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Plasma-derived Medical Product Market Size Growth Rate by Type: 2017 VS 2021 VS 2028
1.2.2 Immune Globulin
1.2.3 Coagulation Factor
1.2.4 Albumin
1.2.5 Other
1.3 Market by Application
1.3.1 Global Plasma-derived Medical Product Market Share by Application: 2017 VS 2021 VS 2028
1.3.2 Hospital
1.3.3 Retail Pharmacy
1.3.4 Other
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Plasma-derived Medical Product Market Perspective (2017-2028)
2.2 Plasma-derived Medical Product Growth Trends by Region
2.2.1 Plasma-derived Medical Product Market Size by Region: 2017 VS 2021 VS 2028
2.2.2 Plasma-derived Medical Product Historic Market Size by Region (2017-2022)
2.2.3 Plasma-derived Medical Product Forecasted Market Size by Region (2023-2028)
2.3 Plasma-derived Medical Product Market Dynamics
2.3.1 Plasma-derived Medical Product Industry Trends
2.3.2 Plasma-derived Medical Product Market Drivers
2.3.3 Plasma-derived Medical Product Market Challenges
2.3.4 Plasma-derived Medical Product Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Plasma-derived Medical Product Players by Revenue
3.1.1 Global Top Plasma-derived Medical Product Players by Revenue (2017-2022)
3.1.2 Global Plasma-derived Medical Product Revenue Market Share by Players (2017-2022)
3.2 Global Plasma-derived Medical Product Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Plasma-derived Medical Product Revenue
3.4 Global Plasma-derived Medical Product Market Concentration Ratio
3.4.1 Global Plasma-derived Medical Product Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Plasma-derived Medical Product Revenue in 2021
3.5 Plasma-derived Medical Product Key Players Head office and Area Served
3.6 Key Players Plasma-derived Medical Product Product Solution and Service
3.7 Date of Enter into Plasma-derived Medical Product Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Plasma-derived Medical Product Breakdown Data by Type
4.1 Global Plasma-derived Medical Product Historic Market Size by Type (2017-2022)
4.2 Global Plasma-derived Medical Product Forecasted Market Size by Type (2023-2028)
5 Plasma-derived Medical Product Breakdown Data by Application
5.1 Global Plasma-derived Medical Product Historic Market Size by Application (2017-2022)
5.2 Global Plasma-derived Medical Product Forecasted Market Size by Application (2023-2028)
6 North America
6.1 North America Plasma-derived Medical Product Market Size (2017-2028)
6.2 North America Plasma-derived Medical Product Market Size by Country (2017-2022)
6.3 North America Plasma-derived Medical Product Market Size by Country (2023-2028)
6.4 United States
6.5 Canada
7 Europe
7.1 Europe Plasma-derived Medical Product Market Size (2017-2028)
7.2 Europe Plasma-derived Medical Product Market Size by Country (2017-2022)
7.3 Europe Plasma-derived Medical Product Market Size by Country (2023-2028)
7.4 Germany
7.5 France
7.6 U.K.
7.7 Italy
7.8 Russia
7.9 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Plasma-derived Medical Product Market Size (2017-2028)
8.2 Asia-Pacific Plasma-derived Medical Product Market Size by Country (2017-2022)
8.3 Asia-Pacific Plasma-derived Medical Product Market Size by Country (2023-2028)
8.4 China
8.5 Japan
8.6 South Korea
8.7 Southeast Asia
8.8 India
8.9 Australia
9 Latin America
9.1 Latin America Plasma-derived Medical Product Market Size (2017-2028)
9.2 Latin America Plasma-derived Medical Product Market Size by Country (2017-2022)
9.3 Latin America Plasma-derived Medical Product Market Size by Country (2023-2028)
9.4 Mexico
9.5 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Plasma-derived Medical Product Market Size (2017-2028)
10.2 Middle East & Africa Plasma-derived Medical Product Market Size by Country (2017-2022)
10.3 Middle East & Africa Plasma-derived Medical Product Market Size by Country (2023-2028)
10.4 Turkey
10.5 Saudi Arabia
10.6 UAE
11 Key Players Profiles
11.1 Takeda
11.1.1 Takeda Company Detail
11.1.2 Takeda Business Overview
11.1.3 Takeda Plasma-derived Medical Product Introduction
11.1.4 Takeda Revenue in Plasma-derived Medical Product Business (2017-2022)
11.1.5 Takeda Recent Development
11.2 CSL
11.2.1 CSL Company Detail
11.2.2 CSL Business Overview
11.2.3 CSL Plasma-derived Medical Product Introduction
11.2.4 CSL Revenue in Plasma-derived Medical Product Business (2017-2022)
11.2.5 CSL Recent Development
11.3 Grifols
11.3.1 Grifols Company Detail
11.3.2 Grifols Business Overview
11.3.3 Grifols Plasma-derived Medical Product Introduction
11.3.4 Grifols Revenue in Plasma-derived Medical Product Business (2017-2022)
11.3.5 Grifols Recent Development
11.4 Octapharma
11.4.1 Octapharma Company Detail
11.4.2 Octapharma Business Overview
11.4.3 Octapharma Plasma-derived Medical Product Introduction
11.4.4 Octapharma Revenue in Plasma-derived Medical Product Business (2017-2022)
11.4.5 Octapharma Recent Development
11.5 Kedrion
11.5.1 Kedrion Company Detail
11.5.2 Kedrion Business Overview
11.5.3 Kedrion Plasma-derived Medical Product Introduction
11.5.4 Kedrion Revenue in Plasma-derived Medical Product Business (2017-2022)
11.5.5 Kedrion Recent Development
11.6 LFB Group
11.6.1 LFB Group Company Detail
11.6.2 LFB Group Business Overview
11.6.3 LFB Group Plasma-derived Medical Product Introduction
11.6.4 LFB Group Revenue in Plasma-derived Medical Product Business (2017-2022)
11.6.5 LFB Group Recent Development
11.7 Biotest
11.7.1 Biotest Company Detail
11.7.2 Biotest Business Overview
11.7.3 Biotest Plasma-derived Medical Product Introduction
11.7.4 Biotest Revenue in Plasma-derived Medical Product Business (2017-2022)
11.7.5 Biotest Recent Development
11.8 BPL
11.8.1 BPL Company Detail
11.8.2 BPL Business Overview
11.8.3 BPL Plasma-derived Medical Product Introduction
11.8.4 BPL Revenue in Plasma-derived Medical Product Business (2017-2022)
11.8.5 BPL Recent Development
11.9 RAAS
11.9.1 RAAS Company Detail
11.9.2 RAAS Business Overview
11.9.3 RAAS Plasma-derived Medical Product Introduction
11.9.4 RAAS Revenue in Plasma-derived Medical Product Business (2017-2022)
11.9.5 RAAS Recent Development
11.10 CBPO
11.10.1 CBPO Company Detail
11.10.2 CBPO Business Overview
11.10.3 CBPO Plasma-derived Medical Product Introduction
11.10.4 CBPO Revenue in Plasma-derived Medical Product Business (2017-2022)
11.10.5 CBPO Recent Development
11.11 Hualan Bio
11.11.1 Hualan Bio Company Detail
11.11.2 Hualan Bio Business Overview
11.11.3 Hualan Bio Plasma-derived Medical Product Introduction
11.11.4 Hualan Bio Revenue in Plasma-derived Medical Product Business (2017-2022)
11.11.5 Hualan Bio Recent Development
11.12 Tiantan Bio
11.12.1 Tiantan Bio Company Detail
11.12.2 Tiantan Bio Business Overview
11.12.3 Tiantan Bio Plasma-derived Medical Product Introduction
11.12.4 Tiantan Bio Revenue in Plasma-derived Medical Product Business (2017-2022)
11.12.5 Tiantan Bio Recent Development
11.13 Shuanglin Bio
11.13.1 Shuanglin Bio Company Detail
11.13.2 Shuanglin Bio Business Overview
11.13.3 Shuanglin Bio Plasma-derived Medical Product Introduction
11.13.4 Shuanglin Bio Revenue in Plasma-derived Medical Product Business (2017-2022)
11.13.5 Shuanglin Bio Recent Development
11.14 Boya Bio
11.14.1 Boya Bio Company Detail
11.14.2 Boya Bio Business Overview
11.14.3 Boya Bio Plasma-derived Medical Product Introduction
11.14.4 Boya Bio Revenue in Plasma-derived Medical Product Business (2017-2022)
11.14.5 Boya Bio Recent Development
11.15 Yuanda Shuyang
11.15.1 Yuanda Shuyang Company Detail
11.15.2 Yuanda Shuyang Business Overview
11.15.3 Yuanda Shuyang Plasma-derived Medical Product Introduction
11.15.4 Yuanda Shuyang Revenue in Plasma-derived Medical Product Business (2017-2022)
11.15.5 Yuanda Shuyang Recent Development
11.16 Weiguang Bio
11.16.1 Weiguang Bio Company Detail
11.16.2 Weiguang Bio Business Overview
11.16.3 Weiguang Bio Plasma-derived Medical Product Introduction
11.16.4 Weiguang Bio Revenue in Plasma-derived Medical Product Business (2017-2022)
11.16.5 Weiguang Bio Recent Development
11.17 Nanyue Bio
11.17.1 Nanyue Bio Company Detail
11.17.2 Nanyue Bio Business Overview
11.17.3 Nanyue Bio Plasma-derived Medical Product Introduction
11.17.4 Nanyue Bio Revenue in Plasma-derived Medical Product Business (2017-2022)
11.17.5 Nanyue Bio Recent Development
11.18 KM Biologics
11.18.1 KM Biologics Company Detail
11.18.2 KM Biologics Business Overview
11.18.3 KM Biologics Plasma-derived Medical Product Introduction
11.18.4 KM Biologics Revenue in Plasma-derived Medical Product Business (2017-2022)
11.18.5 KM Biologics Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of Tables
Table 1. Global Plasma-derived Medical Product Market Size Growth Rate by Type (US$ Million): 2017 VS 2021 VS 2028
Table 2. Key Players of Immune Globulin
Table 3. Key Players of Coagulation Factor
Table 4. Key Players of Albumin
Table 5. Key Players of Other
Table 6. Global Plasma-derived Medical Product Market Size Growth by Application (US$ Million): 2017 VS 2021 VS 2028
Table 7. Global Plasma-derived Medical Product Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
Table 8. Global Plasma-derived Medical Product Market Size by Region (2017-2022) & (US$ Million)
Table 9. Global Plasma-derived Medical Product Market Share by Region (2017-2022)
Table 10. Global Plasma-derived Medical Product Forecasted Market Size by Region (2023-2028) & (US$ Million)
Table 11. Global Plasma-derived Medical Product Market Share by Region (2023-2028)
Table 12. Plasma-derived Medical Product Market Trends
Table 13. Plasma-derived Medical Product Market Drivers
Table 14. Plasma-derived Medical Product Market Challenges
Table 15. Plasma-derived Medical Product Market Restraints
Table 16. Global Plasma-derived Medical Product Revenue by Players (2017-2022) & (US$ Million)
Table 17. Global Plasma-derived Medical Product Market Share by Players (2017-2022)
Table 18. Global Top Plasma-derived Medical Product Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Plasma-derived Medical Product as of 2021)
Table 19. Ranking of Global Top Plasma-derived Medical Product Companies by Revenue (US$ Million) in 2021
Table 20. Global 5 Largest Players Market Share by Plasma-derived Medical Product Revenue (CR5 and HHI) & (2017-2022)
Table 21. Key Players Headquarters and Area Served
Table 22. Key Players Plasma-derived Medical Product Product Solution and Service
Table 23. Date of Enter into Plasma-derived Medical Product Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Plasma-derived Medical Product Market Size by Type (2017-2022) & (US$ Million)
Table 26. Global Plasma-derived Medical Product Revenue Market Share by Type (2017-2022)
Table 27. Global Plasma-derived Medical Product Forecasted Market Size by Type (2023-2028) & (US$ Million)
Table 28. Global Plasma-derived Medical Product Revenue Market Share by Type (2023-2028)
Table 29. Global Plasma-derived Medical Product Market Size by Application (2017-2022) & (US$ Million)
Table 30. Global Plasma-derived Medical Product Revenue Market Share by Application (2017-2022)
Table 31. Global Plasma-derived Medical Product Forecasted Market Size by Application (2023-2028) & (US$ Million)
Table 32. Global Plasma-derived Medical Product Revenue Market Share by Application (2023-2028)
Table 33. North America Plasma-derived Medical Product Market Size by Country (2017-2022) & (US$ Million)
Table 34. North America Plasma-derived Medical Product Market Size by Country (2023-2028) & (US$ Million)
Table 35. Europe Plasma-derived Medical Product Market Size by Country (2017-2022) & (US$ Million)
Table 36. Europe Plasma-derived Medical Product Market Size by Country (2023-2028) & (US$ Million)
Table 37. Asia-Pacific Plasma-derived Medical Product Market Size by Region (2017-2022) & (US$ Million)
Table 38. Asia-Pacific Plasma-derived Medical Product Market Size by Region (2023-2028) & (US$ Million)
Table 39. Latin America Plasma-derived Medical Product Market Size by Country (2017-2022) & (US$ Million)
Table 40. Latin America Plasma-derived Medical Product Market Size by Country (2023-2028) & (US$ Million)
Table 41. Middle East & Africa Plasma-derived Medical Product Market Size by Country (2017-2022) & (US$ Million)
Table 42. Middle East & Africa Plasma-derived Medical Product Market Size by Country (2023-2028) & (US$ Million)
Table 43. Takeda Company Detail
Table 44. Takeda Business Overview
Table 45. Takeda Plasma-derived Medical Product Product
Table 46. Takeda Revenue in Plasma-derived Medical Product Business (2017-2022) & (US$ Million)
Table 47. Takeda Recent Development
Table 48. CSL Company Detail
Table 49. CSL Business Overview
Table 50. CSL Plasma-derived Medical Product Product
Table 51. CSL Revenue in Plasma-derived Medical Product Business (2017-2022) & (US$ Million)
Table 52. CSL Recent Development
Table 53. Grifols Company Detail
Table 54. Grifols Business Overview
Table 55. Grifols Plasma-derived Medical Product Product
Table 56. Grifols Revenue in Plasma-derived Medical Product Business (2017-2022) & (US$ Million)
Table 57. Grifols Recent Development
Table 58. Octapharma Company Detail
Table 59. Octapharma Business Overview
Table 60. Octapharma Plasma-derived Medical Product Product
Table 61. Octapharma Revenue in Plasma-derived Medical Product Business (2017-2022) & (US$ Million)
Table 62. Octapharma Recent Development
Table 63. Kedrion Company Detail
Table 64. Kedrion Business Overview
Table 65. Kedrion Plasma-derived Medical Product Product
Table 66. Kedrion Revenue in Plasma-derived Medical Product Business (2017-2022) & (US$ Million)
Table 67. Kedrion Recent Development
Table 68. LFB Group Company Detail
Table 69. LFB Group Business Overview
Table 70. LFB Group Plasma-derived Medical Product Product
Table 71. LFB Group Revenue in Plasma-derived Medical Product Business (2017-2022) & (US$ Million)
Table 72. LFB Group Recent Development
Table 73. Biotest Company Detail
Table 74. Biotest Business Overview
Table 75. Biotest Plasma-derived Medical Product Product
Table 76. Biotest Revenue in Plasma-derived Medical Product Business (2017-2022) & (US$ Million)
Table 77. Biotest Recent Development
Table 78. BPL Company Detail
Table 79. BPL Business Overview
Table 80. BPL Plasma-derived Medical Product Product
Table 81. BPL Revenue in Plasma-derived Medical Product Business (2017-2022) & (US$ Million)
Table 82. BPL Recent Development
Table 83. RAAS Company Detail
Table 84. RAAS Business Overview
Table 85. RAAS Plasma-derived Medical Product Product
Table 86. RAAS Revenue in Plasma-derived Medical Product Business (2017-2022) & (US$ Million)
Table 87. RAAS Recent Development
Table 88. CBPO Company Detail
Table 89. CBPO Business Overview
Table 90. CBPO Plasma-derived Medical Product Product
Table 91. CBPO Revenue in Plasma-derived Medical Product Business (2017-2022) & (US$ Million)
Table 92. CBPO Recent Development
Table 93. Hualan Bio Company Detail
Table 94. Hualan Bio Business Overview
Table 95. Hualan Bio Plasma-derived Medical ProductProduct
Table 96. Hualan Bio Revenue in Plasma-derived Medical Product Business (2017-2022) & (US$ Million)
Table 97. Hualan Bio Recent Development
Table 98. Tiantan Bio Company Detail
Table 99. Tiantan Bio Business Overview
Table 100. Tiantan Bio Plasma-derived Medical ProductProduct
Table 101. Tiantan Bio Revenue in Plasma-derived Medical Product Business (2017-2022) & (US$ Million)
Table 102. Tiantan Bio Recent Development
Table 103. Shuanglin Bio Company Detail
Table 104. Shuanglin Bio Business Overview
Table 105. Shuanglin Bio Plasma-derived Medical ProductProduct
Table 106. Shuanglin Bio Revenue in Plasma-derived Medical Product Business (2017-2022) & (US$ Million)
Table 107. Shuanglin Bio Recent Development
Table 108. Boya Bio Company Detail
Table 109. Boya Bio Business Overview
Table 110. Boya Bio Plasma-derived Medical ProductProduct
Table 111. Boya Bio Revenue in Plasma-derived Medical Product Business (2017-2022) & (US$ Million)
Table 112. Boya Bio Recent Development
Table 113. Yuanda Shuyang Company Detail
Table 114. Yuanda Shuyang Business Overview
Table 115. Yuanda Shuyang Plasma-derived Medical ProductProduct
Table 116. Yuanda Shuyang Revenue in Plasma-derived Medical Product Business (2017-2022) & (US$ Million)
Table 117. Yuanda Shuyang Recent Development
Table 118. Weiguang Bio Company Detail
Table 119. Weiguang Bio Business Overview
Table 120. Weiguang Bio Plasma-derived Medical ProductProduct
Table 121. Weiguang Bio Revenue in Plasma-derived Medical Product Business (2017-2022) & (US$ Million)
Table 122. Weiguang Bio Recent Development
Table 123. Nanyue Bio Company Detail
Table 124. Nanyue Bio Business Overview
Table 125. Nanyue Bio Plasma-derived Medical ProductProduct
Table 126. Nanyue Bio Revenue in Plasma-derived Medical Product Business (2017-2022) & (US$ Million)
Table 127. Nanyue Bio Recent Development
Table 128. KM Biologics Company Detail
Table 129. KM Biologics Business Overview
Table 130. KM Biologics Plasma-derived Medical ProductProduct
Table 131. KM Biologics Revenue in Plasma-derived Medical Product Business (2017-2022) & (US$ Million)
Table 132. KM Biologics Recent Development
Table 133. Research Programs/Design for This Report
Table 134. Key Data Information from Secondary Sources
Table 135. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Plasma-derived Medical Product Market Share by Type: 2021 VS 2028
Figure 2. Immune Globulin Features
Figure 3. Coagulation Factor Features
Figure 4. Albumin Features
Figure 5. Other Features
Figure 6. Global Plasma-derived Medical Product Market Share by Application in 2021 & 2028
Figure 7. Hospital Case Studies
Figure 8. Retail Pharmacy Case Studies
Figure 9. Other Case Studies
Figure 10. Plasma-derived Medical Product Report Years Considered
Figure 11. Global Plasma-derived Medical Product Market Size (US$ Million), Year-over-Year: 2017-2028
Figure 12. Global Plasma-derived Medical Product Market Size, (US$ Million), 2017 VS 2021 VS 2028
Figure 13. Global Plasma-derived Medical Product Market Share by Region: 2021 VS 2028
Figure 14. Global Plasma-derived Medical Product Market Share by Players in 2021
Figure 15. Global Top Plasma-derived Medical Product Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Plasma-derived Medical Product as of 2021)
Figure 16. The Top 10 and 5 Players Market Share by Plasma-derived Medical Product Revenue in 2021
Figure 17. North America Plasma-derived Medical Product Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 18. North America Plasma-derived Medical Product Market Share by Country (2017-2028)
Figure 19. United States Plasma-derived Medical Product Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 20. Canada Plasma-derived Medical Product Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 21. Europe Plasma-derived Medical Product Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 22. Europe Plasma-derived Medical Product Market Share by Country (2017-2028)
Figure 23. Germany Plasma-derived Medical Product Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 24. France Plasma-derived Medical Product Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 25. U.K. Plasma-derived Medical Product Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 26. Italy Plasma-derived Medical Product Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 27. Russia Plasma-derived Medical Product Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 28. Nordic Countries Plasma-derived Medical Product Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 29. Asia-Pacific Plasma-derived Medical Product Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 30. Asia-Pacific Plasma-derived Medical Product Market Share by Region (2017-2028)
Figure 31. China Plasma-derived Medical Product Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 32. Japan Plasma-derived Medical Product Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 33. South Korea Plasma-derived Medical Product Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 34. Southeast Asia Plasma-derived Medical Product Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 35. India Plasma-derived Medical Product Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 36. Australia Plasma-derived Medical Product Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 37. Latin America Plasma-derived Medical Product Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 38. Latin America Plasma-derived Medical Product Market Share by Country (2017-2028)
Figure 39. Mexico Plasma-derived Medical Product Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 40. Brazil Plasma-derived Medical Product Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 41. Middle East & Africa Plasma-derived Medical Product Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 42. Middle East & Africa Plasma-derived Medical Product Market Share by Country (2017-2028)
Figure 43. Turkey Plasma-derived Medical Product Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 44. Saudi Arabia Plasma-derived Medical Product Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 45. Takeda Revenue Growth Rate in Plasma-derived Medical Product Business (2017-2022)
Figure 46. CSL Revenue Growth Rate in Plasma-derived Medical Product Business (2017-2022)
Figure 47. Grifols Revenue Growth Rate in Plasma-derived Medical Product Business (2017-2022)
Figure 48. Octapharma Revenue Growth Rate in Plasma-derived Medical Product Business (2017-2022)
Figure 49. Kedrion Revenue Growth Rate in Plasma-derived Medical Product Business (2017-2022)
Figure 50. LFB Group Revenue Growth Rate in Plasma-derived Medical Product Business (2017-2022)
Figure 51. Biotest Revenue Growth Rate in Plasma-derived Medical Product Business (2017-2022)
Figure 52. BPL Revenue Growth Rate in Plasma-derived Medical Product Business (2017-2022)
Figure 53. RAAS Revenue Growth Rate in Plasma-derived Medical Product Business (2017-2022)
Figure 54. CBPO Revenue Growth Rate in Plasma-derived Medical Product Business (2017-2022)
Figure 55. Hualan Bio Revenue Growth Rate in Plasma-derived Medical Product Business (2017-2022)
Figure 56. Tiantan Bio Revenue Growth Rate in Plasma-derived Medical Product Business (2017-2022)
Figure 57. Shuanglin Bio Revenue Growth Rate in Plasma-derived Medical Product Business (2017-2022)
Figure 58. Boya Bio Revenue Growth Rate in Plasma-derived Medical Product Business (2017-2022)
Figure 59. Yuanda Shuyang Revenue Growth Rate in Plasma-derived Medical Product Business (2017-2022)
Figure 60. Weiguang Bio Revenue Growth Rate in Plasma-derived Medical Product Business (2017-2022)
Figure 61. Nanyue Bio Revenue Growth Rate in Plasma-derived Medical Product Business (2017-2022)
Figure 62. KM Biologics Revenue Growth Rate in Plasma-derived Medical Product Business (2017-2022)
Figure 63. Bottom-up and Top-down Approaches for This Report
Figure 64. Data Triangulation
Figure 65. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Takeda CSL Grifols Octapharma Kedrion LFB Group Biotest BPL RAAS CBPO Hualan Bio Tiantan Bio Shuanglin Bio Boya Bio Yuanda Shuyang Weiguang Bio Nanyue Bio KM Biologics